Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide (Q31152491)

29 June 2017

title

Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide (English)

1 reference

29 June 2017

Mee Young Kim

1 reference

29 June 2017

Cheol Woo Byeon

1 reference

29 June 2017

Kyung Hee Hong

1 reference

29 June 2017

Ki Hoon Han

1 reference

29 June 2017

Sunjoo Jeong

1 reference

29 June 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

29 June 2017

1 reference

inferred from page(s)

published in

FEBS Letters

1 reference

29 June 2017

volume

579

1 reference

29 June 2017

1 reference

29 June 2017

page(s)

1597-1601

1 reference

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

The amino-terminal domain of CCR2 is both necessary and sufficient for high affinity binding of monocyte chemoattractant protein 1. Receptor activation by a pseudo-tethered ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Specificity determinants for chemokine recognition identified using eotaxin-MCP-1 chimeras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Analysis of the role of chemokines in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Antibody-selectable filamentous fd phage vectors: affinity purification of target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Mimicry of tandem repeat peptides against cell surface carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Eotaxin and monocyte chemotactic protein-3 use different modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Role of the first extracellular loop in the functional activation of CCR2. The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Tumor targeting with a selective gelatinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

New approaches for cell-specific targeting: identification of cell-selective peptides from combinatorial libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.070

10.1016/J.FEBSLET.2005.01.070

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference